	Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024. Eur Urol Cigliola A, Necchi A, Capitanio U. PMID: 42379926 [PubMed - as supplied by publisher]
	Beyond the tumor: Recurrence-prone radiomics for prognostication in negative PSMA PET/CT scans of prostate cancer. Biomed Phys Eng Express Yousefirizi F, Harsini S, Mohebi M, Alberts I, Yusufaly T, Luo M, Abdollahi H, Yazdani E, Mirabedian S, Sabouri M, Geramifar P, Sheikhzadeh P, Martineau P, Wilson D, Bénard F, Uribe CF, Rahmim A. PMID: 42379193 [PubMed - as supplied by publisher]
	Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial. Eur J Cancer Fizazi K, Smith MR, Hussain M, Saad F, Sternberg CN, David Crawford E, Aragon-Ching JB, Schostak M, Tutrone R, Morgans AK, Sentana-Lledo D, Joensuu H, Mohamed AF, Littleton N, Srinivasan S, Buttkewitz Y, Li R, Kuss I, Tombal B. PMID: 42378957 [PubMed - as supplied by publisher]
	Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know. Abdom Radiol (NY) Takahashi S, Miura M, Higashiyama H. PMID: 42380349 [PubMed - as supplied by publisher]
	Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study. Cancer Res Commun Sayyid RK, Tiwari R, Zhang B, Wilton AS, Lajkosz K, Cockburn JG, Bernardino RM, Al-Daqqaq Z, Penn LZ, Goldberg H, Saskin R, Fleshner NE. PMID: 42378436 [PubMed - as supplied by publisher]
	Efficacy, safety, and treatment feasibility of pembrolizumab plus lenvatinib in patients aged 75 years or older with advanced renal cell carcinoma: a Japanese multicenter retrospective study. Int J Clin Oncol Yamashita S, Yamasaki T, Ueda K, Tomida R, Toyoda S, Iwamoto H, Miyake M, Tomisaki I, Morizane S, Kohjimoto Y. PMID: 42377813 [PubMed - as supplied by publisher]
	Angiotensin Converting Enzyme (ACE) insertion/deletion (rs1799752) gene polymorphism and bladder cancer aggressiveness in Egyptian patients: A pilot case-control study. Mol Biol Rep Atia N, Osman Y, Abdel-Aziz AF, Refaat S, Khalil MR, Refaat M. PMID: 42377753 [PubMed - indexed for MEDLINE]
	4D flow MRI for the evaluation of venous anatomy and flow in renal cell carcinoma with venous tumor thrombus: a pictorial essay. Abdom Radiol (NY) Wentland AL, García-Rodríguez S, Roadman DF, Wieben O, Ansari N, Shapiro DD, Abel EJ. PMID: 42377543 [PubMed - as supplied by publisher]
	(18)F-Fluciclovine or (68)Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial. Radiology Abiodun-Ojo OA, Jani AB, Goyal S, Lawal IO, Halkar RK, Dhere V, Shelton JW, Patel PR, Schreibmann E, Hershatter B, Patel SA, Hanasoge S, Sebastian NT, Schuster DM. PMID: 42377125 [PubMed - indexed for MEDLINE]
	Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine. Expert Rev Anticancer Ther Mercinelli C, Di Costanzo F, Oing C, Guandalini G, Maiorano BA, Sammarco E, Salfi A, Serafin D, Tateo V, Cigliola A, Piacentini M, Pastorino GL, Galli L, Conteduca V, Formisano L, Rescigno P, Necchi A. PMID: 42376796 [PubMed - as supplied by publisher]
	Common Bile Duct Diameter in Bladder Urothelial Carcinoma: A Case-Control Study. Cancer Manag Res Dadkhah A, Zolfaghari M, Bagheri SM, Soltani S, Fooladi Z, Emami M. PMID: 42376600 [PubMed]
	State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK). BJUI Compass Aning J, Catto JWF, Martin R, Chatterton K, Mariappan P, Ottley E, Hickey J, McCormack S, Gill S, Szabados B. PMID: 42375995 [PubMed]
	Prostate Cancer: Etiology, Diagnosis, and Treatment. Serican J Med Li C, Li Z, Liu X. PMID: 42375929 [PubMed]
	Does body mass index affect the proper pre-operative grade and stage assessment in patients with prostate cancer undergoing radical prostatectomy? Cent European J Urol Drewa J, Adamowicz J, Juszczak K. PMID: 42375717 [PubMed]
	[Descriptive analytical study of patient survival with vertebral metastases in a rheumatological setting in Togo]. Pan Afr Med J Oniankitan S, Diallo ML, Fianyo E, Ataké AE, Diallo MB, Komi TC, Koffi-Tessio VES, Kakpovi K, Houzou P, Oniankitan O. PMID: 42375555 [PubMed - indexed for MEDLINE]
	Case Report: Immune checkpoint inhibitor-associated myocarditis, myositis, and myasthenia gravis overlap syndrome with flow cytometric phenotyping before and after treatment in a patient with urothelial carcinoma. Front Immunol Gambina K, Tymm C, Paiola M, Tanji K, Zech J, Winchester R, Mor A, Gartshteyn Y. PMID: 42375375 [PubMed - indexed for MEDLINE]
	What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. World J Urol Erdem S, Amparore D, Re C, Verep S, Capitanio U, Larcher A, Roussel E, Klatte T, Bertolo R, Muselaers S, Pavan N, Kara O, Ingels A, Pecoraro A, Marchioni M, Pandolfo SD, Diana P, Carbonara U, Mollica V, Warren H, Borregales L, Marandino L, Sharma G, Caliò A, Wu Z, Lovati LA, Ciccarese C, Margue G, Francolini G, Flippot R, Leung DK, Mjaess G, Rosiello G, Mir MC, Palumbo C, Campi R, EAU-YAU Renal Cancer Working Group. PMID: 42373875 [PubMed - indexed for MEDLINE]
	Circulating metabolite biomarkers associated with prostate cancer risk in Black Americans: findings from the Southern Community Cohort Study. Br J Cancer Yoon HS, Shu XO, Wu J, Sanderson M, Wang X, Wen W, Courtney R, Yang JJ, Blot WJ, Zheng W, Cai Q. PMID: 42373845 [PubMed - as supplied by publisher]
	Reply to Yue Chang's Letter to the Editor re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe trial. Eur Urol Oncol 2026;9:404-12. Eur Urol Oncol Contieri R, Hurle R. PMID: 42373419 [PubMed - as supplied by publisher]
	Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis. Eur Urol Viti A, Scuderi S, Cucchiara V, Gandaglia G, Briganti A, Montorsi F. PMID: 42373361 [PubMed - as supplied by publisher]

Articles 1 - 20 / 179603

Page 1 of 8981



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy